ClinVar Miner

Submissions for variant NM_177438.3(DICER1):c.3713T>C (p.Leu1238Pro)

dbSNP: rs1060503603
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000472528 SCV000553531 uncertain significance DICER1-related tumor predisposition 2025-01-23 criteria provided, single submitter clinical testing This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 1238 of the DICER1 protein (p.Leu1238Pro). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DICER1-related conditions. ClinVar contains an entry for this variant (Variation ID: 412075). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DICER1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV001020955 SCV001182504 uncertain significance Hereditary cancer-predisposing syndrome 2023-05-01 criteria provided, single submitter clinical testing The p.L1238P variant (also known as c.3713T>C), located in coding exon 20 of the DICER1 gene, results from a T to C substitution at nucleotide position 3713. The leucine at codon 1238 is replaced by proline, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Baylor Genetics RCV003470504 SCV004193320 uncertain significance Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 2024-03-22 criteria provided, single submitter clinical testing
GeneDx RCV004767278 SCV005375961 uncertain significance not provided 2023-11-29 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Laboratory of Medical Genetics Unit, Bambino Gesù Children's Hospital RCV004776286 SCV005382020 uncertain significance Childhood kidney cell carcinoma; High-grade astrocytoma with piloid features no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.